EQ
Price
$1.44
Change
+$0.03 (+2.13%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
83.9M
55 days until earnings call
FDMT
Price
$8.45
Change
+$0.84 (+11.04%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
355.41M
42 days until earnings call
Interact to see
Advertisement

EQ vs FDMT

Header iconEQ vs FDMT Comparison
Open Charts EQ vs FDMTBanner chart's image
Equillium
Price$1.44
Change+$0.03 (+2.13%)
Volume$17.38K
Capitalization83.9M
4D Molecular Therapeutics
Price$8.45
Change+$0.84 (+11.04%)
Volume$17.96K
Capitalization355.41M
EQ vs FDMT Comparison Chart in %
Loading...
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EQ vs. FDMT commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQ is a Buy and FDMT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (EQ: $1.41 vs. FDMT: $7.61)
Brand notoriety: EQ and FDMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EQ: 6% vs. FDMT: 84%
Market capitalization -- EQ: $83.9M vs. FDMT: $355.41M
EQ [@Biotechnology] is valued at $83.9M. FDMT’s [@Biotechnology] market capitalization is $355.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EQ’s FA Score shows that 0 FA rating(s) are green whileFDMT’s FA Score has 0 green FA rating(s).

  • EQ’s FA Score: 0 green, 5 red.
  • FDMT’s FA Score: 0 green, 5 red.
According to our system of comparison, both EQ and FDMT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EQ’s TA Score shows that 5 TA indicator(s) are bullish while FDMT’s TA Score has 5 bullish TA indicator(s).

  • EQ’s TA Score: 5 bullish, 4 bearish.
  • FDMT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both EQ and FDMT are a good buy in the short-term.

Price Growth

EQ (@Biotechnology) experienced а -13.50% price change this week, while FDMT (@Biotechnology) price change was +13.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

EQ is expected to report earnings on Nov 18, 2025.

FDMT is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FDMT($355M) has a higher market cap than EQ($83.9M). EQ YTD gains are higher at: 88.452 vs. FDMT (36.625). EQ has higher annual earnings (EBITDA): -19.78M vs. FDMT (-213.2M). FDMT has more cash in the bank: 293M vs. EQ (11.5M). EQ has less debt than FDMT: EQ (259K) vs FDMT (23.1M). EQ has higher revenues than FDMT: EQ (16.6M) vs FDMT (33K).
EQFDMTEQ / FDMT
Capitalization83.9M355M24%
EBITDA-19.78M-213.2M9%
Gain YTD88.45236.625242%
P/E RatioN/AN/A-
Revenue16.6M33K50,303%
Total Cash11.5M293M4%
Total Debt259K23.1M1%
FUNDAMENTALS RATINGS
EQ: Fundamental Ratings
EQ
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EQFDMT
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 6 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
EQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLSDF2.560.04
+1.39%
Pulse Seismic Inc.
CMHHF2.00N/A
N/A
China Merchants Port Holdings Company Limited
LONKF0.33N/A
N/A
Lonking Holdings, Ltd.
DBSDF41.32-0.17
-0.41%
DBS Group Holdings Ltd.
PRVCF0.02-0.01
-26.00%
PreveCeutical Medical Inc.

EQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, EQ has been loosely correlated with MIST. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if EQ jumps, then MIST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EQ
1D Price
Change %
EQ100%
-2.76%
MIST - EQ
41%
Loosely correlated
-3.98%
MTNB - EQ
35%
Loosely correlated
-5.83%
NEVPF - EQ
33%
Loosely correlated
N/A
IMNM - EQ
31%
Poorly correlated
+8.09%
FDMT - EQ
29%
Poorly correlated
+2.84%
More

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with ORKA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+2.84%
ORKA - FDMT
41%
Loosely correlated
-9.27%
RGNX - FDMT
41%
Loosely correlated
-1.43%
ARCT - FDMT
40%
Loosely correlated
-3.66%
CLDX - FDMT
39%
Loosely correlated
-2.53%
IMTX - FDMT
39%
Loosely correlated
+3.94%
More